RecruitingNot ApplicableNCT05700318

Study Using the ShiraTronics Migraine Therapy System

A Pilot Study Assessing Preliminary Safety and Efficacy of The ShiraTronics Migraine Therapy System in Relieving, Interrupting, and Preventing Chronic Migraine

Sponsor

ShiraTronics

Enrollment

40 participants

Start Date

May 5, 2023

Study Type

INTERVENTIONAL

Conditions

Chronic Migraine, Headache

Summary

The purpose of this pilot study is to assess the preliminary safety and efficacy of the ShiraTronics Migraine Therapy System in prophylactic treatment of patients with refractory chronic migraine.

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called neurostimulator for people with chronic migraine, headache. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.